Ketoprofen Prices: Latest Price Trend, Market Analysis and Forecast

Author : ChemAnalyst Data | Published On : 01 Oct 2026

 

 

According to ChemAnalyst, The global Ketoprofen Prices remained firm during the second quarter of 2026, supported by steady pharmaceutical demand, inventory replenishment, export activity, and elevated production expenses. Ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), is widely used in pain-management and anti-inflammatory formulations. Its pricing dynamics are influenced by pharmaceutical manufacturing activity, demand for finished dosage forms, availability of chemical intermediates, energy expenses, transportation costs, and international trade conditions.

During Q2 2026, Ketoprofen prices showed a firm-to-strengthening trend across the major markets. In North America, spot prices strengthened throughout the quarter as pharmaceutical manufacturers replenished inventories ahead of anticipated summer demand cycles. The regional market recorded prices of approximately USD 64,235/MT on a CFR basis.

The Asia-Pacific market recorded a more pronounced increase. In China, the Ketoprofen Price Index increased by 14.551% quarter-over-quarter, reflecting stronger export demand and disciplined market conditions. The average Ketoprofen price in China reached approximately USD 61,666.67/MT on an FOB Shanghai basis during Q2 2026.

In Europe, Ketoprofen prices remained firm as pharmaceutical companies continued regular procurement programs for pain-management products. At the same time, production costs moved upward because of higher prices for chemical intermediates, energy, and transportation, contributing to a stronger cost environment for manufacturers.

Ketoprofen Prices in North America

The North American Ketoprofen market experienced a strengthening trend during Q2 2026. The market was supported primarily by pharmaceutical manufacturers rebuilding inventories and maintaining procurement schedules for pain-management products.

Ketoprofen spot prices strengthened progressively through April and May, while the market maintained firm conditions into June. Buyers continued to replenish inventories, creating a steady procurement environment for producers and distributors. The availability of material and the timing of pharmaceutical purchasing programs remained important factors influencing spot-market activity.

During the quarter, Ketoprofen prices hovered around USD 64,235/MT on a CFR basis. The pricing level reflected a combination of stable pharmaceutical consumption and higher input costs. Pharmaceutical manufacturers typically maintain structured purchasing schedules, and inventory replenishment can have a direct impact on short-term demand for active pharmaceutical ingredients.

The North American market was also influenced by logistics and transportation costs. Freight expenses can affect landed prices for pharmaceutical ingredients, particularly when supply chains depend on imported raw materials or finished API material. Consequently, changes in transportation expenses can contribute to differences between producer-level prices and CFR market quotations.

The firm pricing environment during Q2 2026 indicates that buyers were willing to maintain procurement despite higher market costs. However, the pace of future price increases will depend on inventory levels, pharmaceutical demand, production economics, and the availability of imported material.

Get Real Time Online for Ketoprofen Prices: https://www.chemanalyst.com/Pricing-data/ketoprofen-1692

Ketoprofen Prices in APAC

The Asia-Pacific region recorded the strongest pricing movement among the markets covered during Q2 2026. China remained an important production and export center for Ketoprofen, with market prices responding to stronger overseas demand and disciplined supply conditions.

The Ketoprofen Price Index in China increased by 14.551% quarter-over-quarter during Q2 2026. This increase reflected stronger export demand combined with disciplined market behavior among producers. When export orders increase while suppliers maintain controlled production and inventory levels, the balance between available supply and purchasing requirements can support higher prices.

The average Ketoprofen price in China was approximately USD 61,666.67/MT on an FOB Shanghai basis during the quarter. The FOB quotation reflects the value of material at the export point before international freight and insurance are added, making it an important benchmark for international buyers evaluating Asian supply.

Export demand remained a key pricing factor. Chinese pharmaceutical ingredient producers serve both domestic and international markets, and stronger export requirements can tighten the availability of material for spot buyers. This effect becomes more visible when manufacturers manage production schedules and avoid excessive inventory accumulation.

Production economics also played an important role in the regional market. Ketoprofen manufacturing requires chemical intermediates and other inputs whose prices can influence the overall cost structure. Changes in energy, utilities, labor, transportation, and chemical feedstock expenses can consequently affect producer offers.

The 14.551% quarter-over-quarter increase demonstrates that the APAC market entered Q2 with a considerably firmer pricing environment. Future price movements will depend on export order volumes, pharmaceutical-sector consumption, producer operating rates, raw-material costs, and inventory positions.

Ketoprofen Prices in Europe

The European Ketoprofen market remained firm throughout Q2 2026. Pharmaceutical companies continued their regular procurement programs, particularly for pain-management products, providing consistent underlying demand.

Unlike the more pronounced increase recorded in China, the European market was characterized primarily by sustained firmness. Buyers continued to require regular supplies, while producers faced increasing manufacturing and logistics expenses.

One of the major factors influencing European Ketoprofen prices was the upward movement in production costs. Higher costs for chemical intermediates increased the expense associated with API manufacturing. Energy prices also remained an important component of the production-cost structure because pharmaceutical manufacturing requires reliable energy and utility inputs.

Transportation expenses further contributed to the overall cost environment. Pharmaceutical supply chains often involve multiple stages, including raw-material procurement, API manufacturing, packaging, warehousing, and transportation. Increases at any stage can influence the final delivered price.

European buyers therefore faced a market where regular pharmaceutical demand coincided with higher producer costs. The resulting market conditions supported firm Ketoprofen prices during the quarter.

Key Factors Influencing Ketoprofen Prices

Several factors shaped the global Ketoprofen Prices trend during Q2 2026.

Pharmaceutical Demand

Demand from pharmaceutical manufacturers remained a central pricing factor. Ketoprofen is used in pain-relief and anti-inflammatory formulations, meaning procurement requirements are closely connected with pharmaceutical production schedules and downstream consumption.

Regular purchasing programs helped provide stability to the market, while inventory replenishment in North America contributed to stronger spot-market activity.

Export Demand

Export demand was particularly important in China. Increased overseas requirements supported the 14.551% quarter-over-quarter increase in the Chinese Ketoprofen Price Index.

Export-oriented producers must balance international orders against domestic requirements and available production capacity. Stronger export activity can therefore tighten spot availability and support higher offers.

Raw-Material and Intermediate Costs

Chemical intermediates represent an important part of Ketoprofen manufacturing economics. When intermediate prices increase, producers may face higher conversion costs and seek to recover these expenses through higher selling prices.

The European market specifically experienced upward pressure from increased chemical-intermediate costs during Q2 2026.

Energy Costs

Energy is another important component of pharmaceutical manufacturing. Manufacturing facilities require electricity, heating, cooling, and other utilities throughout the production process.

Higher energy expenses increase the cost base for producers and can contribute to firm API prices, particularly when higher operating costs occur alongside stable demand.

Transportation and Logistics

Transportation costs influenced Ketoprofen pricing across international markets. CFR prices incorporate freight-related considerations, while FOB prices primarily represent material value at the export location.

Differences between the North American CFR quotation and China's FOB Shanghai price therefore reflect not only regional market conditions but also the different commercial bases used for the quotations.

Inventory Replenishment

Inventory management played an important role in North America. Pharmaceutical manufacturers increased replenishment activity ahead of summer demand cycles, supporting stronger spot-market conditions.

Inventory behavior can have a significant short-term influence on API prices. When buyers move from minimal purchasing to active restocking, demand can rise faster than immediate supply availability.

Global Ketoprofen Market Dynamics

The Q2 2026 Ketoprofen market demonstrated regional differences while maintaining an overall firm pricing environment.

North America experienced strengthening spot prices, with quotations around USD 64,235/MT CFR. The movement was supported by pharmaceutical inventory replenishment and steady demand.

China recorded the most notable quantified increase, with the Ketoprofen Price Index rising 14.551% quarter-over-quarter to an average of approximately USD 61,666.67/MT FOB Shanghai.

Europe maintained firm pricing as regular pharmaceutical procurement continued against a backdrop of increasing production expenses.

These regional trends highlight the importance of distinguishing between market-specific drivers when evaluating global Ketoprofen pricing. A stronger Chinese export market does not necessarily translate into an identical price movement in North America or Europe because regional inventories, freight costs, procurement cycles, and local supply conditions differ.

Ketoprofen Production Cost Trend

The Ketoprofen Production Cost Trend moved upward during Q2 2026, particularly in Europe, where producers faced higher expenses for chemical intermediates, energy, and transportation.

Production costs are an important indicator for understanding the sustainability of market prices. When manufacturing expenses rise while demand remains stable, producers may attempt to maintain or increase selling prices to protect margins.

For pharmaceutical APIs, production economics can also be affected by quality-control requirements, regulatory compliance, manufacturing utilization, labor expenses, and environmental management costs. These factors can create a relatively high cost structure compared with less specialized chemical products.

The upward cost environment during Q2 2026 provided additional support to the firm Ketoprofen market, although the ultimate impact on selling prices depended on regional supply-demand conditions.

Book A Demo for Ketoprofen Prices: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Ketoprofen

Demand and Supply Outlook

The short-term outlook for Ketoprofen prices will depend on pharmaceutical purchasing activity, inventory replenishment, export orders, and producer operating rates.

North American demand is likely to remain closely connected with pharmaceutical inventory management and seasonal procurement patterns. If manufacturers continue replenishing stocks, spot-market activity could remain firm.

In APAC, China's export performance will remain a key factor. Continued international demand could support prices, while a slowdown in export orders or increased producer availability could reduce upward pressure.

In Europe, production costs will remain an important variable. Higher intermediate, energy, and logistics expenses could keep the cost base elevated. However, the extent to which these costs are reflected in market prices will depend on buyer resistance, inventory positions, and competitive supply.

Ketoprofen Prices: Regional Comparison

Region

Q2 2026 Market Trend

Indicative Price / Change

Key Drivers

North America

Strengthening

USD 64,235/MT CFR

Inventory replenishment, pharmaceutical demand, logistics

China / APAC

Firm to rising

USD 61,666.67/MT FOB Shanghai; +14.551% QoQ

Export demand, supply discipline, production economics

Europe

Firm

—

Pharmaceutical procurement, intermediates, energy and transportation costs

Conclusion

The second quarter of 2026 presented a firm global market for Ketoprofen Prices, with regional dynamics shaped by pharmaceutical demand, inventory management, export activity, and production costs.

North American Ketoprofen prices strengthened during the quarter as pharmaceutical manufacturers replenished inventories ahead of summer demand cycles, with prices around USD 64,235/MT CFR. China recorded a 14.551% quarter-over-quarter increase in its Ketoprofen Price Index, while the average price reached approximately USD 61,666.67/MT FOB Shanghai.

European prices remained firm as pharmaceutical companies maintained regular procurement programs and producers faced higher costs for chemical intermediates, energy, and transportation.

Going forward, Ketoprofen pricing will depend on the interaction between pharmaceutical demand and supply availability, alongside changes in production inputs and international logistics. Monitoring inventory levels, export orders, manufacturing costs, and regional procurement trends will therefore remain important for buyers, sellers, and market participants assessing the Ketoprofen Price Trend.

 

About Us:

Welcome to ChemAnalyst, a next–generation platform for chemical and petrochemical intelligence where innovation meets practical insight. Recognized as “Product Innovator of the Year 2023” and ranked among the “Top 100 Digital Procurement Solutions Companies,” we lead the digital transformation of the global chemical sector. Our online platform helps companies handle price volatility with structured analysis, real-time pricing, and reliable news and deal updates from across the world. Tracking over 500 chemical prices in more than 40 countries becomes simple and efficient with us.

Contact Us:

Address:

420 Lexington Avenue, Suite 300 New York, NY 10170 United States

Phone: +1 332 258 6602

Email: [email protected]

Website: https://www.chemanalyst.com/

LinkedIn: https://www.linkedin.com/company/chemanalyst/

Facebook: https://www.facebook.com/ChemAnalysts/

Twitter: https://x.com/chemanalysts

YouTube: https://www.youtube.com/@chemanalyst

Instagram: https://www.instagram.com/chemanalyst_